Actinidia chinensis polysaccharide suppresses imatinib resistance and malignant progression in gastrointestinal stromal tumors via the NPM1/PI3K/AKT pathway

Imatinib (IM) resistance is a major clinical challenge in treating gastrointestinal stromal tumors (GIST). This study aimed to investigate the effects and underlying mechanisms of Actinidia chinensis polysaccharide (ACPS) on IM resistance in GIST. The impacts of ACPS on the malignant behaviors of GIST were evaluated using the CCK-8 assay, Western blot analysis, colony formation assay, flow cytometry, wound-healing assay, and Transwell assay, combined with transcriptome sequencing and bioinformatic analysis. Clinical samples from GIST patients and matched adjacent non-tumor tissues were collected to detect the expression of nucleophosmin 1 (NPM1) at both cellular and tissue levels, and an orthotopic mouse tumor model was established to verify the in vitro findings. The results demonstrated that ACPS decreased the IC₅₀ value of IM-resistant GIST cells in a dose- and time-dependent manner, and significantly promoted apoptosis and suppressed cell proliferation and migration. Transcriptomic analysis and experimental validation revealed that NPM1 was abnormally overexpressed in IM-resistant GIST and promoted malignant progression. Mechanistically, ACPS blocked the PI3K/AKT signaling pathway by downregulating NPM1 expression, thereby effectively reversing IM resistance in vitro and suppressing the growth of IM-resistant GIST in vivo. This study reveals that ACPS can overcome IM resistance in GISTs by suppressing the NPM1–PI3K/AKT axis, providing a novel therapeutic strategy for the treatment of IM-resistant GIST.

Authors

Institutions

Publication Details

Journal
Biology Direct
Published
2026-11-17
DOI
https://doi.org/10.1186/s13062-026-01065-y
Primary Topic
Gastrointestinal Tumor Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Actinidia chinensis polysaccharide suppresses imatinib resistance and malignant progression in gastrointestinal stromal tumors via the NPM1/PI3K/AKT pathway

Lulu Cao, Jianping Fan, Jun Qian, Junhua Yu et al.
3 links
Biology Direct
Gastrointestinal Tumor Research and Treatment
article

Actinidia chinensis polysaccharide suppresses imatinib resistance and malignant progression in gastrointestinal stromal tumors via the NPM1/PI3K/AKT pathway

Lulu Cao, Jianping Fan, Jun Qian, Junhua Yu, Dejun Jiang, Hang Lu
article en

Abstract

Imatinib (IM) resistance is a major clinical challenge in treating gastrointestinal stromal tumors (GIST). This study aimed to investigate the effects and underlying mechanisms of Actinidia chinensis polysaccharide (ACPS) on IM resistance in GIST. The impacts of ACPS on the malignant behaviors of GIST were evaluated using the CCK-8 assay, Western blot analysis, colony formation assay, flow cytometry, wound-healing assay, and Transwell assay, combined with transcriptome sequencing and bioinformatic analysis. Clinical samples from GIST patients and matched adjacent non-tumor tissues were collected to detect the expression of nucleophosmin 1 (NPM1) at both cellular and tissue levels, and an orthotopic mouse tumor model was established to verify the in vitro findings. The results demonstrated that ACPS decreased the IC₅₀ value of IM-resistant GIST cells in a dose- and time-dependent manner, and significantly promoted apoptosis and suppressed cell proliferation and migration. Transcriptomic analysis and experimental validation revealed that NPM1 was abnormally overexpressed in IM-resistant GIST and promoted malignant progression. Mechanistically, ACPS blocked the PI3K/AKT signaling pathway by downregulating NPM1 expression, thereby effectively reversing IM resistance in vitro and suppressing the growth of IM-resistant GIST in vivo. This study reveals that ACPS can overcome IM resistance in GISTs by suppressing the NPM1–PI3K/AKT axis, providing a novel therapeutic strategy for the treatment of IM-resistant GIST.

Biology Direct
Wenzhou Medical University (CN), Quzhou City People's Hospital (CN), Quzhou University (CN)
Good health and well-being
Gastrointestinal Tumor Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon